1. Home
  2. Labeler Index
  3. Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc.
  4. 23155-866
  5. Product Images: Gabapentin

Product Images Gabapentin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 11 images provide visual information about the product associated with Gabapentin NDC 23155-866 by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Cockcroft and Gault Equation - 3db34064 46bf 470d aa9a 66c363c27fa6 01

Cockcroft and Gault Equation - 3db34064 46bf 470d aa9a 66c363c27fa6 01

Image - 3db34064 46bf 470d aa9a 66c363c27fa6 02

Image - 3db34064 46bf 470d aa9a 66c363c27fa6 02

Figure 1. Weekly Mean Pain Scores (Observed Cases in ITT Population): Study 1 - 3db34064 46bf 470d aa9a 66c363c27fa6 03

Figure 1. Weekly Mean Pain Scores (Observed Cases in ITT Population): Study 1 - 3db34064 46bf 470d aa9a 66c363c27fa6 03

Figure 2. Weekly Mean Pain Scores (Observed Cases in ITT Population): Study 2 - 3db34064 46bf 470d aa9a 66c363c27fa6 04

Figure 2. Weekly Mean Pain Scores (Observed Cases in ITT Population): Study 2 - 3db34064 46bf 470d aa9a 66c363c27fa6 04

Figure 3. Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies - 3db34064 46bf 470d aa9a 66c363c27fa6 05

Figure 3. Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies - 3db34064 46bf 470d aa9a 66c363c27fa6 05

This text appears to be a description regarding the proportion of responders in controlled PHN (Postherpetic Neuralgia) studies. It shows the percentage of patients with more than 50% reduction in pain score at the endpoint of the studies. The text also includes the results of Study 1 and Study 2, along with the corresponding placebo (PBO) and GBP (unknown abbreviation) dosages. However, specific details are not clear due to the limitations of output.*

Figure 4. Responder Rate in Patients Receiving Gabapentin Expressed as a Difference from Placebo by Dose and Study: Adjunctive Therapy Studies in Patients ≥ 12 Years of Age with Partial Seizures - 3db34064 46bf 470d aa9a 66c363c27fa6 06

Figure 4. Responder Rate in Patients Receiving Gabapentin Expressed as a Difference from Placebo by Dose and Study: Adjunctive Therapy Studies in Patients ≥ 12 Years of Age with Partial Seizures - 3db34064 46bf 470d aa9a 66c363c27fa6 06

logo - 3db34064 46bf 470d aa9a 66c363c27fa6 07

logo - 3db34064 46bf 470d aa9a 66c363c27fa6 07

logo - 3db34064 46bf 470d aa9a 66c363c27fa6 08

logo - 3db34064 46bf 470d aa9a 66c363c27fa6 08

Gabapentin Capsules 300mg - 100S - HDPE Bottle Label - 3db34064 46bf 470d aa9a 66c363c27fa6 09

Gabapentin Capsules 300mg - 100S - HDPE Bottle Label - 3db34064 46bf 470d aa9a 66c363c27fa6 09

Gabapentin Capsules 400mg - 100S - HDPE Bottle Label - 3db34064 46bf 470d aa9a 66c363c27fa6 10

Gabapentin Capsules 400mg - 100S - HDPE Bottle Label - 3db34064 46bf 470d aa9a 66c363c27fa6 10

cont-label-100mg-100s - 3db34064 46bf 470d aa9a 66c363c27fa6 11

cont-label-100mg-100s - 3db34064 46bf 470d aa9a 66c363c27fa6 11

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.